316 related articles for article (PubMed ID: 8798258)
1. Neutrophil elastase/alpha 1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral beta-carotene supplementation.
Winklhofer-Roob BM; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Suter S; Shmerling DH
Pediatr Res; 1996 Jul; 40(1):130-4. PubMed ID: 8798258
[TBL] [Abstract][Full Text] [Related]
2. Effects of long-term oral beta-carotene supplementation on lipid peroxidation in patients with cystic fibrosis.
Rust P; Eichler I; Renner S; Elmadfa I
Int J Vitam Nutr Res; 1998; 68(2):83-7. PubMed ID: 9565821
[TBL] [Abstract][Full Text] [Related]
3. Human neutrophil elastase and elastase/alpha 1-antiprotease complex in cystic fibrosis. Comparison with interstitial lung disease and evaluation of the effect of intravenously administered antibiotic therapy.
Meyer KC; Lewandoski JR; Zimmerman JJ; Nunley D; Calhoun WJ; Dopico GA
Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):580-5. PubMed ID: 1892298
[TBL] [Abstract][Full Text] [Related]
4. Enhanced resistance to oxidation of low density lipoproteins and decreased lipid peroxide formation during beta-carotene supplementation in cystic fibrosis.
Winklhofer-Roob BM; Puhl H; Khoschsorur G; van't Hof MA; Esterbauer H; Shmerling DH
Free Radic Biol Med; 1995 May; 18(5):849-59. PubMed ID: 7797092
[TBL] [Abstract][Full Text] [Related]
5. Plasma vitamin C concentrations in patients with cystic fibrosis: evidence of associations with lung inflammation.
Winklhofer-Roob BM; Ellemunter H; Frühwirth M; Schlegel-Haueter SE; Khoschsorur G; van't Hof MA; Shmerling DH
Am J Clin Nutr; 1997 Jun; 65(6):1858-66. PubMed ID: 9174484
[TBL] [Abstract][Full Text] [Related]
6. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum.
Hansen G; Schuster A; Zubrod C; Wahn V
Respiration; 1995; 62(3):117-24. PubMed ID: 7569330
[TBL] [Abstract][Full Text] [Related]
7. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
[TBL] [Abstract][Full Text] [Related]
8. Effect of recombinant human DNase on alpha1-proteinase inhibitor function: an experimental approach to the combined clinical use of rhDNase and alpha1-PI in CF patients.
Hansen G; Hoffjan S; Mosler K; Schuster A
Lung; 2001; 179(3):185-94. PubMed ID: 11891608
[TBL] [Abstract][Full Text] [Related]
9. Long-term oral beta-carotene supplementation in patients with cystic fibrosis - effects on antioxidative status and pulmonary function.
Rust P; Eichler I; Renner S; Elmadfa I
Ann Nutr Metab; 2000; 44(1):30-7. PubMed ID: 10838464
[TBL] [Abstract][Full Text] [Related]
10. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
[TBL] [Abstract][Full Text] [Related]
11. Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis.
Lepage G; Champagne J; Ronco N; Lamarre A; Osberg I; Sokol RJ; Roy CC
Am J Clin Nutr; 1996 Jul; 64(1):87-93. PubMed ID: 8669420
[TBL] [Abstract][Full Text] [Related]
12. Evidence for increased oxidative damage in patients with cystic fibrosis.
Brown RK; Kelly FJ
Pediatr Res; 1994 Oct; 36(4):487-93. PubMed ID: 7816524
[TBL] [Abstract][Full Text] [Related]
13. Prolastin aerosol therapy and sputum taurine in cystic fibrosis.
Cantin AM; Berthiaume Y; Cloutier D; Martel M
Clin Invest Med; 2006 Aug; 29(4):201-7. PubMed ID: 16986483
[TBL] [Abstract][Full Text] [Related]
14. alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients.
Griese M; Latzin P; Kappler M; Weckerle K; Heinzlmaier T; Bernhardt T; Hartl D
Eur Respir J; 2007 Feb; 29(2):240-50. PubMed ID: 17050563
[TBL] [Abstract][Full Text] [Related]
15. Reduced free-radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis.
Langley SC; Brown RK; Kelly FJ
Pediatr Res; 1993 Mar; 33(3):247-50. PubMed ID: 8460060
[TBL] [Abstract][Full Text] [Related]
16. Lipid peroxide, beta-carotene and alpha-tocopherol in ischaemic stroke and effect of exogenous vitamin E supplementation on outcome.
Daga MK; Madhuchhanda ; Mishra TK; Mohan A
J Assoc Physicians India; 1997 Nov; 45(11):843-6. PubMed ID: 11229181
[TBL] [Abstract][Full Text] [Related]
17. beta-Carotene attenuates peroxide-induced vasoconstriction in the human placenta.
Cueto SM; Romney AD; Wang Y; Walsh SW
J Soc Gynecol Investig; 1997; 4(2):64-71. PubMed ID: 9101463
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of neutrophil elastase in CF sputum by L-658,758.
Rees DD; Brain JD; Wohl ME; Humes JL; Mumford RA
J Pharmacol Exp Ther; 1997 Dec; 283(3):1201-6. PubMed ID: 9399994
[TBL] [Abstract][Full Text] [Related]
19. Supplementation with antioxidants prior to bone marrow transplantation.
Clemens MR; Waladkhani AR; Bublitz K; Ehninger G; Gey KF
Wien Klin Wochenschr; 1997 Oct; 109(19):771-6. PubMed ID: 9370141
[TBL] [Abstract][Full Text] [Related]
20. Protection against acute lung injury by intravenous or intratracheal pretreatment with EPI-HNE-4, a new potent neutrophil elastase inhibitor.
Delacourt C; Hérigault S; Delclaux C; Poncin A; Levame M; Harf A; Saudubray F; Lafuma C
Am J Respir Cell Mol Biol; 2002 Mar; 26(3):290-7. PubMed ID: 11867337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
